MedPath

Tolerance of Teeth Brushing During Prolonged Aplasia

Phase 3
Conditions
Aplasia
Interventions
Drug: Mouthwashes
Device: Toothbrush
Registration Number
NCT03879252
Lead Sponsor
University Hospital, Angers
Brief Summary

It is currently not allowed for patients with prolonged aplasia, following intensive chemotherapy, to brush teeth due to the risk of damaging the oral mucosa with risk of haemorrhage and infectious entrance door. Mouthwash is currently prescribed to prevent these complications. Many patients, however, ask to brush their teeth for greater comfort and a feeling of well-being.

Some haematology services allow tooth brushing while others prohibit tooth brushing without study.

Investigators wanted to conduct a study to assess the feasibility, the safety of tooth brushing for aplastic patient comfort, hemopathy and/or chemotherapies causing mucous membrane alteration that increases infectious risk and the risk of gingivorragia.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Hospitalized Patients in protected area of the Blood Disease Service with predictable prolonged aplasia and risk of mucite
  • Acute myeloblastic leukemia undergoing induction or consolidation treatment
  • Acute lymphoblastic leukemia under induction treatment
  • Patients affiliated or beneficiaries of a social security
  • Written inform consent
Exclusion Criteria
  • Patients with removable complete dentures
  • Constitutional disorder of coagulation
  • Hematopoietic stem cell allogreffe
  • Therapeutic intensification with autograft of haematopoietic stem cells
  • Patient unable to provide oral care alone (brushing teeth or mouthwash)
  • Already included in the study
  • Pregnant women, lactating mothers
  • Persons deprived of liberty by an administrative or judicial decision
  • Persons undergoing psychiatric care under duress
  • Adults who are subject to a legal or non-state protection measure to express their consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MouthwashMouthwashes-
Tooth brushingToothbrush-
Primary Outcome Measures
NameTimeMethod
Highest score obtained at the OAG (Oral Assessment Guide) scale during the observation period1 month

Assess the effect of the "teeth brushing" versus "mouth bath" strategy on the oral condition of patients hospitalized in the protected area of the Blood Disease Service with predictable prolonged aplasia and risk of mucite

Secondary Outcome Measures
NameTimeMethod
Number of days with intra-oral hemorrhage1 month

Estimate the effect of the strategy in terms of Hemorrhagic risk

Number of days with fever1 month

Estimate the effect of the strategy in terms of Infectious risks

Incidence of bacterial infections during hospitalization1 month

Estimate the effect of the strategy in terms of Infectious risks

Number of septicemia1 month

Estimate the effect of the strategy in terms of Infectious risks

Incidence of intra-oral hemorrhage1 month

Estimate the effect of the strategy in terms of Hemorrhagic risk

Incidence of fungal infections during hospitalization1 month

Estimate the effect of the strategy in terms of appearance of mucite

Percentage of patients receiving morphinics during hospitalization1 month

Estimate the effect of the strategy in terms of pain

Number of days with morphinic treatment1 month

Estimate the effect of the strategy in terms of pain

Percentage of patients receiving parenteral nutrition during hospitalization1 month

Estimate the effect of the strategy in terms of patient's tolerance to oral care

Number of days with parenteral nutrition1 month

Estimate the effect of the strategy in terms of patient's tolerance to oral care

Percentage of patients who had to discontinue treatment on medical advice1 month

Estimate the effect of the strategy in terms of patient's tolerance to oral care

© Copyright 2025. All Rights Reserved by MedPath